Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BioMimetic Therapeutics, Inc.
BioMimetic Therapeutics, Inc. Announces an $8 Million Private Placement
April 25th, 2009
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced that on April 3, 2009, the Company entered into a definitive purchase agreement with InterWest Partners X, LP, an affiliate of InterWest Partners, one of the Company’s existing stockholders, for the private placement of 941,177 shares of its common stock at a price of $8.50 per share. The purchase price represents a significant premium to the market price ($7.45 per share) of the Common Stock on the date of execution of the purchase agreement. The transaction is expected to raise approximately $8.0 million in gross proceeds. The closing of the financing is expected to occur as soon as practicable, subject to the satisfaction of...
Source: Law & Health Weekly (2009-04-25)
|
